Showing results (981-990 of 6,500) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|March 10, 2012
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patientsEmilie P Buddingh, S Eriaty N Ruslan, Dagmar Berghuis, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2011
Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patientsKei Suzuki, Kyuichi Kadota, Camelia S Sima, et al.
Cancer Immunology, Immunotherapy : CII|August 20, 2011
Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomasJie Chen, Guosheng Li, Hong Meng, et al.
Cancer Immunology, Immunotherapy : CII|July 23, 2011
The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposureRomina Molinari, Donatella D'Eliseo, Laura Manzi, et al.
Cancer Immunology, Immunotherapy : CII|July 23, 2011
Prognostic impact of B-cell density in cutaneous melanomaAndrea Ladányi, Judit Kiss, Anita Mohos, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growthNicolás Amiano, R Macarena Reiteri, María J Costa, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinomaLu-jun Chen, Jing Sun, Hong-ya Wu, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2011
A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cellsChi-Chen Lin, Yen-Ling Yu, Chia-Chiao Shih, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2011
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccinationChiara Tieppo, Corrado Betterle, Daniela Basso, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinomaJoshua M Lang, Mahazarin R Kaikobad, Marianne Wallace, et al.
Pageof 650